<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7118541/results/search/test_trace/results.xml">
  <result pre="tiotropium bromide may also be effective for SARS-CoV-2. Abstract The" exact="infection" post="of a novel coronavirus found in Wuhan of China"/>
  <result pre="rate is increasing worldwide. Due to the lack of effective" exact="treatment" post="options for SARS-CoV-2, various strategies are being tested in"/>
  <result pre="agents, such as Kaletra (lopinavir/ritonavir), could be used for the" exact="treatment" post="of SARS-CoV-2. Overall, we suggest that the list of"/>
  <result pre="by the MT-DTI model should be considered, when establishing effective" exact="treatment" post="strategies for SARS-CoV-2. Keywords COVID-19 SARS-CoV-2 Coronavirus MT-DTI Deep"/>
  <result pre="MERS-CoV), indicating that there is an urgent need for effective" exact="treatment" post="at the beginning of the outbreak to prevent the"/>
  <result pre="[11]. These replication-associated proteins are the primary targets of post-entry" exact="treatment" post="drugs to suppress viral replication. Although much intensive effort"/>
  <result pre="Vina (version 1.1.2), which is a molecular docking and virtual" exact="screening" post="application [17], was used to predict binding affinities (kcal/mol)"/>
  <result pre="inhibiting SARS-CoV-2. Lastly, atazanavir appears to be effective in the" exact="treatment" post="of COVID-19 by showing overall high binding affinities among"/>
  <result pre="to treat coronavirusWall Street J2020 30ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax593200425225614985565 31WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect"/>
 </snippets>
</snippetsTree>
